{"id":519714,"date":"2021-07-29T07:05:54","date_gmt":"2021-07-29T11:05:54","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/sutro-biopharma-to-participate-in-the-12th-annual-wedbush-pacgrow-healthcare-virtual-conference\/"},"modified":"2021-07-29T07:05:54","modified_gmt":"2021-07-29T11:05:54","slug":"sutro-biopharma-to-participate-in-the-12th-annual-wedbush-pacgrow-healthcare-virtual-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/sutro-biopharma-to-participate-in-the-12th-annual-wedbush-pacgrow-healthcare-virtual-conference\/","title":{"rendered":"Sutro Biopharma to Participate in the 12th Annual Wedbush PacGrow Healthcare Virtual Conference"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n SOUTH SAN FRANCISCO, Calif.<\/span>, July 29, 2021<\/span> \/PRNewswire\/ —\u00a0Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer and autoimmune therapeutics, today announced that Chief Executive Officer, Bill Newell<\/span>, will participate in a panel titled “ADCs \u2013 Take Me to Your Tumor” at the 12th<\/sup> Annual Wedbush PacGrow Healthcare Virtual Conference on Wednesday, August 11<\/span>, at 2:20 p.m. ET<\/span> \/ 11:20 a.m. PT<\/span>. <\/p>\n

A live webcast of the presentation will be accessible through the News and Events page of the Investor Relations section on the company’s website at\u00a0www.sutrobio.com<\/a>. Archived replays of the webcasts will be available on the company’s website for approximately 30 days following each live presentation.<\/p>\n

\n About Sutro Biopharma<\/b>\u00a0
Sutro Biopharma, Inc., located in South San Francisco<\/span>, is a clinical-stage drug discovery, development and manufacturing company. Using precise protein engineering and rational design, Sutro is advancing next-generation oncology therapeutics.\u00a0<\/p>\n

Sutro’s proprietary and integrated cell-free protein synthesis platform\u00a0XpressCF\u00ae<\/sup>\u202fand site-specific conjugation platform XpressCF+\u2122 led to the discovery of STRO-001 and STRO-002, Sutro’s first two\u00a0internally-developed\u00a0ADCs. STRO-001 is a CD74-targeting ADC currently being investigated in a Phase 1 clinical trial of patients with advanced B-cell malignancies, including multiple myeloma and non-Hodgkin lymphoma. STRO-001 was granted Orphan Drug Designation by the FDA for multiple myeloma in October 2018<\/span>. STRO-002 is a folate receptor alpha (FolR\u03b1)-targeting ADC, currently being investigated in a Phase 1 clinical trial of patients with ovarian and endometrial cancers. A third product candidate, CC-99712 (BCMA-targeting ADC), which is part of Sutro’s collaboration with Bristol Myers Squibb (formerly Celgene Corporation), is enrolling patients for its Phase 1 clinical trial of patients with multiple myeloma\u00a0and has received Orphan Drug Designation from the FDA for multiple myeloma. A fourth product candidate, M1231, (MUC1-EGFR, first-in-class bispecific ADC), which is part of Sutro’s collaboration with Merck\u00a0KGaA, EMD Serono (EMD Serono) is enrolling patients for its Phase 1 clinical trial of patients with metastatic solid tumors, non-small cell lung cancer (NSCLC) and esophageal squamous cell carcinoma. The four product candidates above being evaluated in clinical trials resulted from Sutro’s\u00a0XpressCF\u00ae<\/sup>\u202fand\u00a0XpressCF+\u2122 technology platforms. Bristol Myers Squibb<\/span> and EMD Serono have worldwide development and commercialization rights for CC-99712 and M1231, respectively, for which Sutro is entitled to milestone or contingent payments and tiered royalties.\u00a0<\/p>\n

Sutro is dedicated to transforming the lives of cancer patients by creating medicines with improved therapeutic profiles for areas of unmet need. To date, Sutro’s platform has led to cytokine-based immuno-oncology therapies, ADCs,\u00a0vaccines\u00a0and bispecific antibodies directed at precedented targets in clinical indications where the current standard of care is suboptimal.\u00a0<\/p>\n

The platform allows it to accelerate discovery and development of potential first-in-class and best-in-class molecules through rapid and systematic evaluation of protein structure-activity relationships to create optimized homogeneous product candidates.\u00a0<\/p>\n

In addition to developing its own oncology pipeline, Sutro is collaborating with select pharmaceutical and biotech companies to discover and develop novel, next-generation therapeutics. As the pace of clinical development accelerates, Sutro and its partners are developing therapeutics designed to\u00a0more efficiently kill tumors\u00a0without harming healthy cells.\u00a0<\/p>\n

Follow Sutro on Twitter,\u202f@Sutrobio<\/a><\/u>, and at\u202fwww.sutrobio.com<\/a><\/u>\u202fto learn more about our passion for changing the future of oncology.\u00a0<\/p>\n

\n Investor Contacts<\/b>\u00a0
Annie J. Chang\u00a0
Sutro Biopharma\u00a0
(650) 801-5728\u00a0
ajchang@sutrobio.com<\/a><\/u>\u00a0<\/p>\n

\n Media Contacts<\/b>\u00a0
Maggie Beller\u00a0
Russo Partners\u00a0
(646) 942-5631\u00a0
Maggie.beller@russopartnersllc.com<\/a><\/u>\u00a0<\/p>\n

\u00a0<\/p>\n

\n \"Cision\" View original content:https:\/\/www.prnewswire.com\/news-releases\/sutro-biopharma-to-participate-in-the-12th-annual-wedbush-pacgrow-healthcare-virtual-conference-301344036.html<\/a><\/p>\n

SOURCE Sutro Biopharma<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire SOUTH SAN FRANCISCO, Calif., July 29, 2021 \/PRNewswire\/ —\u00a0Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer and autoimmune therapeutics, today announced that Chief Executive Officer, Bill Newell, will participate in a panel titled “ADCs \u2013 Take Me to Your Tumor” at the 12th Annual Wedbush PacGrow Healthcare Virtual Conference on Wednesday, August 11, at 2:20 p.m. ET \/ 11:20 a.m. PT. A live webcast of the presentation will be accessible through the News and Events page of the Investor Relations section on the company’s website at\u00a0www.sutrobio.com. Archived replays of the webcasts will be available on the company’s website … <\/p>\n

Continue reading “Sutro Biopharma to Participate in the 12th Annual Wedbush PacGrow Healthcare Virtual Conference”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-519714","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nSutro Biopharma to Participate in the 12th Annual Wedbush PacGrow Healthcare Virtual Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/sutro-biopharma-to-participate-in-the-12th-annual-wedbush-pacgrow-healthcare-virtual-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sutro Biopharma to Participate in the 12th Annual Wedbush PacGrow Healthcare Virtual Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire SOUTH SAN FRANCISCO, Calif., July 29, 2021 \/PRNewswire\/ —\u00a0Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer and autoimmune therapeutics, today announced that Chief Executive Officer, Bill Newell, will participate in a panel titled “ADCs \u2013 Take Me to Your Tumor” at the 12th Annual Wedbush PacGrow Healthcare Virtual Conference on Wednesday, August 11, at 2:20 p.m. ET \/ 11:20 a.m. PT. A live webcast of the presentation will be accessible through the News and Events page of the Investor Relations section on the company’s website at\u00a0www.sutrobio.com. Archived replays of the webcasts will be available on the company’s website … Continue reading "Sutro Biopharma to Participate in the 12th Annual Wedbush PacGrow Healthcare Virtual Conference"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/sutro-biopharma-to-participate-in-the-12th-annual-wedbush-pacgrow-healthcare-virtual-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-29T11:05:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY58432&sd=2021-07-29\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sutro-biopharma-to-participate-in-the-12th-annual-wedbush-pacgrow-healthcare-virtual-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sutro-biopharma-to-participate-in-the-12th-annual-wedbush-pacgrow-healthcare-virtual-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Sutro Biopharma to Participate in the 12th Annual Wedbush PacGrow Healthcare Virtual Conference\",\"datePublished\":\"2021-07-29T11:05:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sutro-biopharma-to-participate-in-the-12th-annual-wedbush-pacgrow-healthcare-virtual-conference\\\/\"},\"wordCount\":591,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sutro-biopharma-to-participate-in-the-12th-annual-wedbush-pacgrow-healthcare-virtual-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NY58432&sd=2021-07-29\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sutro-biopharma-to-participate-in-the-12th-annual-wedbush-pacgrow-healthcare-virtual-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sutro-biopharma-to-participate-in-the-12th-annual-wedbush-pacgrow-healthcare-virtual-conference\\\/\",\"name\":\"Sutro Biopharma to Participate in the 12th Annual Wedbush PacGrow Healthcare Virtual Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sutro-biopharma-to-participate-in-the-12th-annual-wedbush-pacgrow-healthcare-virtual-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sutro-biopharma-to-participate-in-the-12th-annual-wedbush-pacgrow-healthcare-virtual-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NY58432&sd=2021-07-29\",\"datePublished\":\"2021-07-29T11:05:54+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sutro-biopharma-to-participate-in-the-12th-annual-wedbush-pacgrow-healthcare-virtual-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sutro-biopharma-to-participate-in-the-12th-annual-wedbush-pacgrow-healthcare-virtual-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sutro-biopharma-to-participate-in-the-12th-annual-wedbush-pacgrow-healthcare-virtual-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NY58432&sd=2021-07-29\",\"contentUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NY58432&sd=2021-07-29\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sutro-biopharma-to-participate-in-the-12th-annual-wedbush-pacgrow-healthcare-virtual-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sutro Biopharma to Participate in the 12th Annual Wedbush PacGrow Healthcare Virtual Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sutro Biopharma to Participate in the 12th Annual Wedbush PacGrow Healthcare Virtual Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/sutro-biopharma-to-participate-in-the-12th-annual-wedbush-pacgrow-healthcare-virtual-conference\/","og_locale":"en_US","og_type":"article","og_title":"Sutro Biopharma to Participate in the 12th Annual Wedbush PacGrow Healthcare Virtual Conference - Market Newsdesk","og_description":"PR Newswire SOUTH SAN FRANCISCO, Calif., July 29, 2021 \/PRNewswire\/ —\u00a0Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer and autoimmune therapeutics, today announced that Chief Executive Officer, Bill Newell, will participate in a panel titled “ADCs \u2013 Take Me to Your Tumor” at the 12th Annual Wedbush PacGrow Healthcare Virtual Conference on Wednesday, August 11, at 2:20 p.m. ET \/ 11:20 a.m. PT. A live webcast of the presentation will be accessible through the News and Events page of the Investor Relations section on the company’s website at\u00a0www.sutrobio.com. Archived replays of the webcasts will be available on the company’s website … Continue reading \"Sutro Biopharma to Participate in the 12th Annual Wedbush PacGrow Healthcare Virtual Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/sutro-biopharma-to-participate-in-the-12th-annual-wedbush-pacgrow-healthcare-virtual-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-29T11:05:54+00:00","og_image":[{"url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY58432&sd=2021-07-29","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sutro-biopharma-to-participate-in-the-12th-annual-wedbush-pacgrow-healthcare-virtual-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sutro-biopharma-to-participate-in-the-12th-annual-wedbush-pacgrow-healthcare-virtual-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Sutro Biopharma to Participate in the 12th Annual Wedbush PacGrow Healthcare Virtual Conference","datePublished":"2021-07-29T11:05:54+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sutro-biopharma-to-participate-in-the-12th-annual-wedbush-pacgrow-healthcare-virtual-conference\/"},"wordCount":591,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sutro-biopharma-to-participate-in-the-12th-annual-wedbush-pacgrow-healthcare-virtual-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY58432&sd=2021-07-29","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sutro-biopharma-to-participate-in-the-12th-annual-wedbush-pacgrow-healthcare-virtual-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/sutro-biopharma-to-participate-in-the-12th-annual-wedbush-pacgrow-healthcare-virtual-conference\/","name":"Sutro Biopharma to Participate in the 12th Annual Wedbush PacGrow Healthcare Virtual Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sutro-biopharma-to-participate-in-the-12th-annual-wedbush-pacgrow-healthcare-virtual-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sutro-biopharma-to-participate-in-the-12th-annual-wedbush-pacgrow-healthcare-virtual-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY58432&sd=2021-07-29","datePublished":"2021-07-29T11:05:54+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sutro-biopharma-to-participate-in-the-12th-annual-wedbush-pacgrow-healthcare-virtual-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/sutro-biopharma-to-participate-in-the-12th-annual-wedbush-pacgrow-healthcare-virtual-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sutro-biopharma-to-participate-in-the-12th-annual-wedbush-pacgrow-healthcare-virtual-conference\/#primaryimage","url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY58432&sd=2021-07-29","contentUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY58432&sd=2021-07-29"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sutro-biopharma-to-participate-in-the-12th-annual-wedbush-pacgrow-healthcare-virtual-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Sutro Biopharma to Participate in the 12th Annual Wedbush PacGrow Healthcare Virtual Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/519714","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=519714"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/519714\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=519714"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=519714"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=519714"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}